Form 4: Entera Bio Director Gerald Ostrov Acquires and Disposes of Shares
SEC Form 4 Filing
Director Gerald Ostrov reports acquiring 8,452 Entera Bio shares and disposing of 38,898 shares in a recent transaction.
Summary
- On October 2, 2024, Gerald M. Ostrov, a director of Entera Bio Ltd., engaged in a transaction involving the company's ordinary shares.
- Ostrov acquired 8,452 ordinary shares at a price of $0.
- Simultaneously, Ostrov disposed of 38,898 ordinary shares.
- Following these transactions, the total number of shares beneficially owned by Ostrov is not explicitly stated in this report.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a change in beneficial ownership. It doesn't inherently convey positive or negative sentiment, but rather reports a transaction.
Key Dates
| Date | Description |
|---|---|
| 10/02/2024 | Date of the share acquisition and disposal transaction. |
| 10/04/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.